Oregon/Hawaii Node, Clinical Trials Network

俄勒冈/夏威夷节点，临床试验网络

• 批准号: 6959722
• 负责人: DENNIS MCCARTY
• 金额: $ 124.86万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-09-30 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6959722
• 关键词: adolescence (12-20); behavioral /social science research tag; clinical research; clinical trials; cognitive behavior therapy; combination therapy; community health services; cooperative study; counseling; disease /therapy duration; drug /alcohol abstinence; drug abuse therapy; drug addiction; health services research tag; human subject; human therapy evaluation; longitudinal human study; marijuana abuse; motivation; patient oriented research

DESCRIPTION (provided by applicant): The Oregon/Hawaii Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) is a bi-directional clinical trial partnership that includes community treatment programs (CTPs) and a Regional Research and Training Center (RRTC) hosted at Oregon Health & Science University (with support from the Kaiser Permanente Center for Health Research in Honolulu, Hawaii and Portland, Oregon). Eight multi-modality drug abuse treatment programs located in urban and rural communities in Oregon, Hawaii and Washington State participate in the node: Adapt (Roseburg, OR), CODA (Portland, OR), ChangePoint (Portland, OR and Vancouver, WA), Kaiser Permanente Hawaii Department of Behavioral Medicine (Honolulu, HI), Kaiser Permanente Northwest Department of Addiction Medicine (Salem and Portland, OR and Longview and Vancouver, WA), Native American Rehabilitation Association, Northwest (Portland, OR), New Directions Northwest (Baker City, OR), Willamette Family (Eugene, OR). The application has one specific aim: Continue and expand a clinical research partnership that participates fully in the National Drug Abuse Treatment Clinical Trials Network and provides a) effective implementation and completion of clinical trials including rapid and efficient recruitment of study participants, b) leadership to CTN committees and subcommittees, c) bi-directional research concepts, d) collaborative publication with treatment providers and other nodes, and e) a foundation for training and research proposals that enhance CTN capacity. The Node has high standards for participant recruitment and retention in trials, quality assurance reviews, protocol training, participation in CTN leadership, development of systems for electronic case report forms, bi-directional communication, collaboration with other nodes, and good citizenship. The Oregon/Hawaii Node has proven its ability to be a strong and productive CTN member.

描述(由申请人提供)： 国家药物滥用治疗临床试验网络(CTN)的俄勒冈州/夏威夷节点是一个双向临床试验伙伴关系，其中包括由俄勒冈健康与科学大学(Oregon Health&Science University)主办的社区治疗计划(CTP)和一个区域研究和培训中心(RRTC)(得到夏威夷火奴鲁鲁和俄勒冈州波特兰的Kaiser Permanente健康研究中心的支持)。位于俄勒冈州、夏威夷州和华盛顿州城市和农村社区的8个多模式药物滥用治疗计划参与了该节点：Adapt(Roseburg，OR)、CODA(波特兰，OR)、ChangePoint(波特兰，OR和温哥华，华盛顿州)、Kaiser Permanente Hawaii行为医学部(火奴鲁鲁，HI)、Kaiser Permanente西北成瘾医学部(Salem和Portland，OR以及Longview和Vancouver，WA)、美国原住民康复协会(Portland，OR)、西北(Baker City，OR)、威拉米特家庭(Eugene，OR)。该申请有一个明确的目标：继续和扩大临床研究伙伴关系，全面参与国家药物滥用治疗临床试验网络，并提供a)有效实施和完成临床试验，包括快速和高效地招募研究参与者，b)领导CTN委员会和小组委员会，c)双向研究概念，d)与治疗提供者和其他节点合作出版，以及e)为提高CTN能力的培训和研究建议奠定基础。该节点在招募和保留试验参与者、质量保证审查、礼仪培训、参与CTN领导、开发电子案例报告表格系统、双向沟通、与其他节点的合作以及良好公民意识等方面具有高标准。俄勒冈州/夏威夷节点已经证明了它有能力成为一个强大而富有成效的CTN成员。